Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2007

01-12-2007 | Short communication

Benefits of complementary therapies

Author: Caroline Hoffman

Published in: Breast Cancer Research | Special Issue 2/2007

Login to get access

Excerpt

This paper examines the benefits of complementary therapies, as supported by research evidence, in patients with breast cancer. Complementary therapies are those therapies and approaches used alongside medical treatment for breast cancer to support the patient on their cancer journey. It should be added that an integrated approach to cancer care includes the best of the orthodox medical treatments and the best evidence-based, supportive complementary modalities. …
Literature
1.
Olson K, Hanson J, Michaud M: A phase II trial of reiki for the management of pain in advanced cancer patients. J Pain Symptom Manage. 2003, 26: 990-997. 10.1016/S0885-3924(03)00334-8.CrossRefPubMed
2.
He JP, Friedrich M, Ertan AK, Muller K, Schmidt W: Pain-relief and movement improvement by acupuncture after ablation and axillary lymphadenectomy in patients with mammary cancer. Clin Exp Obstet Gynecol. 1999, 26: 81-84.PubMed
3.
Mehling WE, Jacobs B, Acree M, Wilson L, Bostrom A, West J, Acquah J, Burns B, Chapman J, Hecht FM: Symptom management with massage and acupuncture in postoperative cancer patients: a randomised controlled trial. J Pain Symptom Manage. 2007, 33: 258-266. 10.1016/j.jpainsymman.2006.09.016.CrossRefPubMed
4.
Alimi D, Rubino C, Pichard-Léandri E, Fermand-Brulé S, Dubreuil-Lemaire ML, Hill C: Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol. 2003, 21: 4120-4126. 10.1200/JCO.2003.09.011.CrossRefPubMed
5.
Mundy EA, DuHamel KN, Montgomery GH: The efficacy of behavioral interventions for cancer treatment-related side effects. Semin Clin Neuropsychiatry. 2003, 8: 253-275.PubMed
6.
Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ: Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systemic review. J Clin Oncol. 2006, 24: 5457-5464. 10.1200/JCO.2006.08.3725.CrossRefPubMed
7.
Montgomery GH, Bovbjerg DH, Schnur JB, David D, Goldfarb A, Weltz CR, Schechter C, Graff-Zivin J, Tatrow K, Price DD, et al: A randomized clinical trial of a brief hypnosis intervention to control side effects of breast cancer surgery patients. J Natl Cancer Inst. 2007, 99: 1304-1312. 10.1093/jnci/djm106.CrossRefPubMed
8.
Ezzo J, Vickers A, Richardson MA, Allen C, Dibble SL, Issell B, Lao L, Pearl M, Ramirez G, Roscoe JA, et al: Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Review and meta-analysis. J Clin Oncol. 2005, 23: 7188-7198. 10.1200/JCO.2005.06.028.CrossRefPubMed
9.
Klein J, Griffiths P: Acupressure for nausea and vomiting in cancer patients receiving chemotherapy. Br J Comm Nurs. 2004, 9: 383-387.CrossRef
10.
Molassiotis A, Helin AM, Dabbour R, Hummerston S: The effects of P6 acupressure in the prophylaxis of chemotherapy-related nausea and vomiting in breast cancer patients. Complement Ther Med. 2007, 15: 3-12. 10.1016/j.ctim.2006.07.005.CrossRefPubMed
11.
Roscoe JA, Matteson SE, Morrow GR, Hickok JT, Bushunow P, Griggs J, Qazi R, Smith B, Kramer Z, Smith J: Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer. J Pain Symptom Manage. 2005, 29: 376-384. 10.1016/j.jpainsymman.2004.07.007.CrossRefPubMed
12.
Post-White J, Kinney ME, Savik K, Gau JB, Wilcox C, Lerner I: Therapeutic massage and healing touch improve symptoms in cancer. Integr Cancer Ther. 2003, 2: 332-344. 10.1177/1534735403259064.CrossRefPubMed
13.
Stephenson NL, Weinrich SP, Tavakoli AS: The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer. Oncol Nurs Forum. 2000, 27: 67-72.PubMed
14.
Cohen M, Fried G: Comparing relaxation training and Cognitive-Behavioural group therapy for women with breast cancer. Res Social Work Pract. 2007, 17: 313-323. 10.1177/1049731506293741.CrossRef
15.
Kienle GS, Kiene H: Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur J Med Res. 2007, 12: 103-119.PubMed
16.
Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, O'Fallon JR, Laurie JA, Shanahan TG, Moore RL, et al: Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol. 1996, 36: 345-349. 10.1016/S0360-3016(96)00320-3.CrossRef
17.
Olsen DL, Raub W, Bradley C, Johnson M, Macias JL, Love V, Markoe A: The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy. Oncol Nurs Forum. 2001, 28: 543-547.PubMed
18.
Balzarini A, Felisi E, Martini A, De Conno F: Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomised, double blind clinical trial. Br Homeopath J. 2000, 89: 8-12. 10.1054/homp.1999.0328.CrossRefPubMed
19.
Schlappack O: Homeopathic treatment of radiation-induced itching in breast cancer patients. A prospective observational study. Homeopathy. 2004, 93: 210-215. 10.1016/j.homp.2004.06.004.CrossRefPubMed
20.
Smith J, Richardson J, Filshie J, Thomas R, Moir F, Pilkington K: Acupuncture for hot flushes as a result of cancer treatment: a systematic review. Complementary and Alternative Medicine Evidence Online (CAMEOL) Database. 2005, [http://​www.​rccm.​org.​uk/​cameol]
21.
Nedstrand E, Wijma K, Wyon Y, Hammar M: Vasomotor symptoms decrease in women with breast cancer randomised to treatment with applied relaxation or electroacupuncture: a preliminary study. Climacteric. 2005, 8: 243-250. 10.1080/13697130500118050.CrossRefPubMed
22.
Shapiro SL, Bootzin RR, Figueredo AJ, Lopez AM, Schwartz GE: The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer. An exploratory study. J Psychosom Res. 2003, 54: 85-91. 10.1016/S0022-3999(02)00546-9.CrossRefPubMed
23.
Fellowes D, Barnes K, Wilkinson S: Aromatherapy and massage for symptom relief in patients with cancer. Cochrane Database Syst Rev. 2004, 3: CD002287-
24.
CAMEOL: Cancer (general): Aromatherapy: a review of the research evidence on the effectiveness of aromatherapy and/or massage for cancer symptom management. Complementary and Alternative Medicine Evidence Online (CAMEOL) Database. [http://​www.​rccm.​org.​uk/​cameol]
25.
Wilkinson SM, Love SB, Westcombe AM, Gambles MA, Burgess CC, Cargill A, Young T, Maher EJ, Ramirez AJ: Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol. 2007, 25: 532-539. 10.1200/JCO.2006.08.9987.CrossRefPubMed
26.
Fellowes D, Gambles M, Lockhart-Wood K, Wilkinson S: Reflexology for symptom relief in patients with cancer. (Protocol.). Cochrane Database Syst Rev. 2000, CD002917-DOI: 10.1002/14651858.CD002917
27.
Speca M, Carlson LE, Goodey E, Angen M: A randomised, wait-list controlled clinical trial: the effect of mindfulness meditation based stress reduction programme on mood and symptoms in cancer outpatients. Psychosom Med. 2000, 62: 613-622.CrossRefPubMed
28.
Carlson LE, Speca M, Kamala DP, Goodey E: Mindfulness-based stress reduction in relation to life, mood, symptoms of stress and levels of cortisol, dehydoepiandrosterone-sulphate (DHEAS) and melotonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004, 29: 448-474. 10.1016/S0306-4530(03)00054-4.CrossRefPubMed
29.
McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK: Potential of chemotherapy-herb interactions in adult cancer patients. Support Cancer Care. 2004, 12: 454-462. 10.1007/s00520-004-0598-1.CrossRef
30.
Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM: Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002, 137: 889-903.CrossRefPubMed
31.
Izzo AA, Ernst E: Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001, 61: 2163-2175. 10.2165/00003495-200161150-00002.CrossRefPubMed
32.
Sparreboom A, Cox MC, Acharya MR, Figg WD: Herbal remedies in the United States: potential interactions with anticancer agents. J Clin Oncol. 2004, 22: 2489-2503. 10.1200/JCO.2004.08.182.CrossRefPubMed
33.
D'Andrea GM: The use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin. 2005, 55: 319-321.CrossRefPubMed
Metadata
Title
Benefits of complementary therapies
Author
Caroline Hoffman
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2007
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1807

Other articles of this Special Issue 2/2007

Breast Cancer Research 2/2007 Go to the issue

Short communication

Do classical oestrogen markers predict for clinical response to endocrine therapy?

Short communication

Is breast cancer advocacy distorting the cancer budget to the disadvantage of other tumours?

Short communication

Adjuvant treatment: the contribution of expression microarrays

Section introduction

Introduction to sessions on Personalising treatment

Short communication

The dangers of complementary therapy

Short communication

Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits